Ian Greenberg
- Role
- VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio at GSK
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Ian Greenberg
16 years leading complex transactions by leveraging experience in drug discovery…
Experience
VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio
Sep 2020 — Present
2.0bn acquisition of Bellus - camlipixant (Ph3)- Scynexis license Ibrexa (Approved) upfront $90m - Spero license Tebi (Ph3) Upfront $66m & equity up to 19.9%-$1.9bn acquisition of Sierra Oncology - momelotinib (Ph3)
Skills
- Finance
- Sales
- Strategic Planning
- Diabetes
- Clinical Development
- Market Research
- Budgets
- Pharmacokinetics
- Oncology
- Valuation
- Drug Discovery
- Assay Development
- Business Development
- Negotiation
- Pharmaceutical Sales
- Mergers & Acquisitions
- Leadership
- Pharmaceutical Industry
- Clinical Trials
- Protein Chemistry
- High Throughput Screening
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.